Asia Pacific Proteomics Market

The Asia Pacific proteomics market is projected to reach USD 16.61 billion by 2030 from USD 8.57 billion in 2025, at a CAGR of 14.1%. The growth of this market is attributed to several key factors, such as strong government funding for precision medicine, cancer research, and population-scale health initiatives, and rising adoption of mass spectrometry-based and immunoassay-based proteomics in academic and hospital research labs.

The key players in the Asia Pacific (APAC) proteomics market with a strong footprint include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies (US), Bruker Corporation (US), Shimadzu Corporation (Japan), Bio-Rad Laboratories Inc. (US), Waters Corporation (US), and QIAGEN (Netherlands). In the APAC proteomics industry, these players are shifting their focus from traditional protein analysis systems to high-throughput and automated systems that include cutting-edge sample preparation, mass spectrometry, and sequence-based proteomics, as well as specialized reagents and kits for difficult biologics and multi-omics analysis. By establishing robust manufacturing networks and developing distribution channels, as well as building hardware and software ecosystems, companies are expanding their presence in markets such as China, Japan, South Korea, India, and Southeast Asia. This expansion is helping to meet the increasing demand for proteome-wide analysis and personalized medicine initiatives, which encompass areas from discovery and translational research to the rapidly growing field of clinical research.

In May 2024, Shimadzu Corporation launched the LCMS-8060RX, LCMS-8050RX, and LCMS-8045RX triple quadrupole high-performance liquid chromatograph mass spectrometers, designed to deliver more reliable data through enhanced high sensitivity and stability while boosting laboratory efficiency with automatic calibration.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific (US)

Thermo Fisher Scientific is a major player in the APAC market, utilizing the strengths of its Orbitrap mass spectrometry platforms, automatic sample preparation instruments, and bioinformatics tools. With the incorporation of Olink’s High-Plex Proteomics Platform, the company continues to position itself as a full-end Solutions Supplier for the biopharma, CRO, and Academic Centers of China, Japan, South Korea, and Australia Markets, supporting the scalable and multiplex nature of precision medicine and translational studies.

Danaher Corporation (US)

SCIEX and Cytiva, a business unit of Danaher, are making an impact on the APAC proteomics community by providing solutions for high-throughput LC-MS systems, capillary electrophoresis, and robust sample handling. Collaborations and shared best practices, such as joint development of standardized high-throughput proteomics analytical processes with collaborators such as Evosep, are empowering pharmaceutical and biotechnology industries and core laboratories within the APAC region to enhance protein quantification.

Agilent Technologies (US)

Agilent Technologies is helping to foster the proteomics community within the Asia Pacific region with its integrated LC-MS triple-quadrupole and Q-TOF systems, along with validated workflows and Spectrum Mill software to provide accurate peptide and protein quantification. The company is facilitating research institutions and clinical labs within Asia Pacific to produce high-quality proteomics data through its application-driven partnerships and engagement with plasma and targeted proteomics research.

Market Ranking

For the Asia Pacific proteomics industry, Thermo Fisher Scientific offers the unique combination of Orbitrap mass spectrometry, Olink-enabled high-plex analyses, and efficient, automation-friendly workflows to easily transition scientists from raw materials to proteomic knowledge. Danaher, through its SCIEX and Cytiva brands, features standardized high-throughput LC-MS, sample handling solutions, and collaborative strategies promoting more efficient, regular proteomics analyses in the pharmaceutical industry’s core laboratories. Agilent Technologies provides integrated proteomic solutions through its Accurate-Mass-ToF mass spectrometry, enabling efficient peptide analysis, easy integration into larger multi-omics studies, and proteomic results through its advanced Spectrum Mill software. Bruker Corporation addresses proteomics through the application of high-resolution, fast-scanning mass spectrometry instruments, integrated analytical solutions, designed for existing APAC interests in high-end, advanced proteomics techniques. Shimadzu Corporation uses its mass spectrometry and analytical solutions, designed to provide proteomics to a diverse range of industries.

Related Reports:

Asia Pacific Proteomics Market by Instrumentation Technology [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com